Atlas Trials

Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)

Clinical trial NCT02260505 · COMPLETED

Trial details

NCT number
NCT02260505
Sponsor
Centre Leon Berard
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gastrointestinal Stromal TumorsResected Gastrointestinal Stromal TumorsNon-metastaticHigh Risk of RecurrenceKIT Gene Mutation
Start date
2014-12-24
Primary completion
2023-12-01
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.